Engineers Gate Manager LP Novartis Ag Transaction History

Engineers Gate Manager LP

$4.86 Billion
Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Novartis Ag stock. As of the latest transaction made, Engineers Gate Manager LP holds 5,927 shares of NVS stock, worth $618,067. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,927

Previous 12,648 53.14%

Holding current value

$618,067

Previous $1.35 Million 49.41%

% of portfolio

0.01%

Previous 0.03%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $713,299 - $812,501	-6,721 Reduced 53.14%	5,927 $681,000
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $2.41 Million - $2.8 Million	-26,032 Reduced 67.3%	12,648 $1.35 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $2.45 Million - $2.79 Million	25,702 Added 198.04%	38,680 $3.74 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $813,821 - $895,582	8,820 Added 212.12%	12,978 $1.31 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $710,285 - $788,264	-7,498 Reduced 64.33%	4,158 $423,000
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $1.08 Million - $1.22 Million	11,656 New	11,656 $1.18 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $318,733 - $372,774	-4,272 Reduced 44.5%	5,328 $405,000
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $772,992 - $900,000	9,600 New	9,600 $811,000
Q2 2020 Aug 17, 2020	SELL	$80.93 - $91.1 $222,557 - $250,524	-2,750 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $55,829 - $78,217	-790 Reduced 22.32%	2,750 $227,000
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $298,599 - $337,609	3,540 New	3,540 $335,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Novartis Ag Transaction History